V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009654 | 330003517 | 1.82 | 73 | Curative (C) | 2015-06-19 | 2015-07-16 | METHOTREXATE | null | null | 330003643 | METHOTREXATE |
| 330009655 | 330003520 | 1.82 | 51 | Curative (C) | 2018-03-10 | 2018-03-20 | MIFAMURTIDE | N | Y | 330003651 | MIFAMURTIDE |
| 330009656 | 330003520 | 0 | 125.6 | Curative (C) | 2017-11-16 | 2018-04-04 | MIFAMURTIDE | N | N | 330003651 | MIFAMURTIDE |
| 330009657 | 330003523 | 1.65 | 49.6 | Curative (C) | null | 2015-03-28 | Cisplatin | null | null | 330003677 | CISPLATIN |
| 330009658 | 330003523 | 1.72 | null | Adjuvant (A) | 2016-02-12 | 2016-06-03 | Mifamurtide weeks 1-12 | N | N | 330003677 | MIFAMURTIDE |
| 330009661 | 330003527 | null | 107 | Curative (C) | null | 2015-08-26 | Methotrexate Intermed dose (1g/m2) | Y | null | 330003708 | METHOTREXATE |
| 330009662 | 330003529 | 1.82 | null | Neo-adjuvant (N) | 2012-10-02 | 2013-04-23 | Mifamurtide weeks 13-36 | N | N | 330003721 | MIFAMURTIDE |
| 330009663 | 330003531 | 1.66 | 64.3 | Curative (C) | null | 2016-10-09 | Doxorubin 50mg/m2 | N | null | 330003728 | DOXORUBICIN |
| 330009664 | 330003532 | null | 81 | Curative (C) | 2014-01-25 | 2014-07-12 | Mifamurtide weeks 1-12 | Y | null | 330003734 | MIFAMURTIDE |
| 330009665 | 330007893 | null | 104.6 | Curative (C) | null | 2017-05-12 | Mifamurtide weeks 1-12 | Y | null | 330003743 | MIFAMURTIDE |
| 330009667 | 330003541 | null | 48.4 | Adjuvant (A) | null | 2016-09-08 | Mifamurtide weeks 1-12 | Y | null | 330004198 | MIFAMURTIDE |
| 330009668 | 330007898 | 1.77 | 84.1 | Curative (C) | null | 2014-01-31 | Cisplatin 7 day | Y | null | 330004563 | CISPLATIN |
| 330009669 | 330003544 | 1.61 | 31 | null | 2017-10-17 | 2017-11-12 | Trial Unspecified | N | null | 330004796 | TRIAL |
| 330009670 | 330003547 | 1.72 | 62 | Curative (C) | 2014-11-28 | 2015-02-26 | Cisplatin 7 day | N | N | 330004842 | CISPLATIN |
| 330009671 | 330003549 | null | null | Curative (C) | 2015-02-15 | 2015-03-10 | EW EuroEwing 2012 Arm A VAI | N | null | 330004950 | TRIAL |
| 330009672 | 330007905 | 0 | null | Curative (C) | 2017-06-26 | 2017-06-26 | METHOTREXATE | N | N | 330004963 | METHOTREXATE |
| 330009673 | 330003553 | 0 | 22.65 | Curative (C) | 2016-08-28 | 2017-01-08 | MIFAMURTIDE | Y | N | 330004971 | MIFAMURTIDE |
| 330009674 | 330003555 | 0 | 60.7 | Neo-adjuvant (N) | 2016-04-12 | 2018-01-29 | Mifamurtide weeks 13-36 | N | N | 330004985 | MIFAMURTIDE |
| 330009675 | 330003558 | 1.68 | 58.3 | Neo-adjuvant (N) | 2016-10-08 | 2016-10-13 | METHOTREXATE | 02 | N | 330005004 | METHOTREXATE |
| 330009676 | 330010301 | 1.71 | 41 | Adjuvant (A) | 2016-02-06 | 2016-07-30 | Doxorubicin 75mg/m2 | N | N | 330005070 | DOXORUBICIN |
| 330009677 | 330003562 | null | null | Curative (C) | 2014-09-14 | 2014-09-22 | Cisplatin | N | N | 330005089 | CISPLATIN |
| 330009678 | 330003563 | 1.77 | 60.1 | Curative (C) | 2015-12-29 | 2016-03-31 | Cisplatin 7 day | null | N | 330005090 | CISPLATIN |
| 330009679 | 330003563 | 1.76 | 61.4 | Neo-adjuvant (N) | 2014-02-12 | 2014-03-18 | LAMB TRIAL | N | null | 330005090 | TRIAL |
| 330009680 | 330003570 | 1.75 | 67.4 | Adjuvant (A) | 2016-09-22 | 2017-06-18 | OST Mifamurtide | Y | N | 330005138 | MIFAMURTIDE |
| 330009682 | 330003574 | 1.81 | 55.5 | Neo-adjuvant (N) | null | 2015-09-16 | METHOTREXATE | N | null | 330005160 | METHOTREXATE |
| 330009683 | 330003576 | 1.51 | 62.1 | Curative (C) | 2017-08-24 | 2017-10-23 | Cisplatin | Y | N | 330005162 | CISPLATIN |
| 330009684 | 330003577 | 1.9 | 0 | Disease modification (D) | null | 2014-01-14 | Methotrexate + Folinic acid | N | null | 330005195 | METHOTREXATE |
| 330009685 | 330003579 | 1.79 | 66 | Adjuvant (A) | 2014-08-23 | 2014-08-26 | EW EuroEwing 2012 Arm A VAI | null | null | 330005201 | TRIAL |
| 330009686 | 330003580 | 0 | null | Curative (C) | null | 2018-07-07 | MIFAMURTIDE | null | null | 330005203 | MIFAMURTIDE |
| 330009687 | 330003583 | 1.6 | 58.6 | Neo-adjuvant (N) | 2018-02-18 | 2018-05-03 | Cisplatin | N | N | 330005204 | CISPLATIN |
| 330009688 | 330007925 | null | null | Curative (C) | 2013-07-23 | 2013-08-15 | Cisplatin 7 day | N | null | 330005221 | CISPLATIN |
| 330009689 | 330003587 | 1.79 | 49.35 | Adjuvant (A) | 2013-11-20 | 2013-12-18 | Cisplatin | N | null | 330005241 | CISPLATIN |
| 330009690 | 330003589 | null | null | Adjuvant (A) | 2018-04-03 | 2018-04-04 | Doxorubicin 75mg/m2 | N | N | 330005262 | DOXORUBICIN |
| 330009691 | 330003592 | 1.88 | 32.5 | Palliative (P) | 2014-11-21 | 2015-03-24 | METHOTREXATE | Y | Y | 330005264 | METHOTREXATE |
| 330009692 | 330003596 | 0 | 11.2 | Adjuvant (A) | 2016-10-05 | 2017-02-11 | Mifamurtide weeks 1-12 | N | N | 330005285 | MIFAMURTIDE |
| 330009693 | 330003598 | 1.54 | null | Palliative (P) | 2016-10-05 | 2017-08-11 | DOXORUBICIN | N | N | 330005287 | DOXORUBICIN |
| 330009694 | 330003600 | null | 65.1 | null | 2017-06-23 | 2017-06-24 | DOXORUBICIN | N | Y | 330005294 | DOXORUBICIN |
| 330009695 | 330012350 | null | 82.25 | Palliative (P) | 2017-08-08 | 2017-08-08 | EW EuroEwing 2012 Arm B IE | null | N | 330005300 | TRIAL |
| 330009696 | 330012350 | 0 | 28.6 | Curative (C) | 2014-07-19 | 2014-07-21 | METHOTREXATE | 2 | N | 330005300 | METHOTREXATE |
| 330009697 | 330003605 | 1.7 | 59 | Neo-adjuvant (N) | 2014-10-24 | 2014-10-24 | EW EuroEwing 2012 Arm A VAI | N | N | 330005313 | TRIAL |
| 330009698 | 330007935 | 1.72 | 47.3 | Neo-adjuvant (N) | 2018-05-17 | 2018-06-21 | Cisplatin 7 day | 2 | N | 330005315 | CISPLATIN |
| 330009699 | 330003608 | 1.77 | 91.6 | Curative (C) | 2014-01-25 | 2014-04-02 | Trial Unspecified | 02 | N | 330005325 | TRIAL |
| 330009700 | 330003611 | 0 | 62.4 | Adjuvant (A) | 2015-03-21 | 2015-08-15 | MIFAMURTIDE | 02 | N | 330005334 | MIFAMURTIDE |
| 330009701 | 330003613 | 1.77 | null | Palliative (P) | 2015-07-10 | 2015-08-05 | OST Euramos 1 Closed Trial - IE | N | N | 330005358 | TRIAL |
| 330009702 | 330003615 | 1.75 | 54.7 | Curative (C) | 2015-06-08 | 2015-08-15 | Cisplatin 7 day | 01 | N | 330005388 | CISPLATIN |
| 330009703 | 330007942 | 1.8 | null | Curative (C) | 2016-06-10 | 2016-07-11 | METHOTREXATE | null | N | 330005418 | METHOTREXATE |
| 330009704 | 330003623 | 1.83 | 54.2 | Curative (C) | null | 2013-09-26 | Mifamurtide weeks 13-36 | null | null | 330005439 | MIFAMURTIDE |
| 330009705 | 330003626 | 1.64 | 67.6 | Neo-adjuvant (N) | null | 2016-06-30 | Methotrexate + Folinic acid | N | N | 330005461 | METHOTREXATE |
| 330009706 | 330003631 | 1.61 | 42.4 | Curative (C) | 2018-02-28 | 2018-03-02 | MIFAMURTIDE | N | N | 330005520 | MIFAMURTIDE |
| 330009707 | 330003635 | 1.54 | 92.1 | Curative (C) | 2018-08-15 | 2018-08-25 | Trial Unspecified | N | N | 330005520 | TRIAL |